In 50 years, cancer survival rates will increase fourfold. This was stated by Professor Stephen Powis, a leading doctor at the UK's National Health Service, in an interview with The Telegraph.

According to him, lung cancer will become “much less common” thanks to vaccines that have proven effective in clinical trials.

“And also tests that identify the genetic profile of lung and breast cancer tumors, allowing patients to quickly receive personalized treatment plans,” he added.

The professor noted that in recent years, advances in immunotherapy, drug treatment, and early detection have made it possible to significantly increase the life expectancy of patients while maintaining their quality of life.